Business Segments · Asset impairment and related disposal costs
Business Segments — Asset impairment and related disposal costs
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026Apr 28, 2026
Rolls up toImpairment of assets held for sale
How to read this metric
Frequent or large impairments suggest poor capital allocation or failure in the R&D pipeline.
Detailed definition
This represents non-cash charges taken when the carrying value of an asset, such as a drug program or intangible asset,...
Peer comparison
Commonly reported by peers during portfolio rationalization or after failed clinical trials.
Metric ID:
incy_segment_reportable_segment_asset_impairment_and_related_disposal_costsHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $0.00 | $23.21M |
Range$0.00 – $23.21M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's business segments — asset impairment and related disposal costs?
- Incyte (INCY) reported business segments — asset impairment and related disposal costs of $23.21M in Q1 2026.
- What does business segments — asset impairment and related disposal costs mean?
- The cost of writing down the value of assets that are no longer expected to perform as planned.